Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP109198.RAvIqJjSS6ThU-f_1FhQO7LoXb1VLt-CfWpyMtErZ_NMA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP109198.RAvIqJjSS6ThU-f_1FhQO7LoXb1VLt-CfWpyMtErZ_NMA130_assertion type Assertion NP109198.RAvIqJjSS6ThU-f_1FhQO7LoXb1VLt-CfWpyMtErZ_NMA130_head.
- NP109198.RAvIqJjSS6ThU-f_1FhQO7LoXb1VLt-CfWpyMtErZ_NMA130_assertion description "[Eight single nucleotide polymorphisms in ERCC2, XPC, XPA, ERCC1, ERCC4 and ERCC5 genes were analyzed in 91 patients diagnosed with osteosarcoma and treated with cisplatin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109198.RAvIqJjSS6ThU-f_1FhQO7LoXb1VLt-CfWpyMtErZ_NMA130_provenance.
- NP109198.RAvIqJjSS6ThU-f_1FhQO7LoXb1VLt-CfWpyMtErZ_NMA130_assertion evidence source_evidence_literature NP109198.RAvIqJjSS6ThU-f_1FhQO7LoXb1VLt-CfWpyMtErZ_NMA130_provenance.
- NP109198.RAvIqJjSS6ThU-f_1FhQO7LoXb1VLt-CfWpyMtErZ_NMA130_assertion SIO_000772 19434073 NP109198.RAvIqJjSS6ThU-f_1FhQO7LoXb1VLt-CfWpyMtErZ_NMA130_provenance.
- NP109198.RAvIqJjSS6ThU-f_1FhQO7LoXb1VLt-CfWpyMtErZ_NMA130_assertion wasDerivedFrom gad-20150221 NP109198.RAvIqJjSS6ThU-f_1FhQO7LoXb1VLt-CfWpyMtErZ_NMA130_provenance.
- NP109198.RAvIqJjSS6ThU-f_1FhQO7LoXb1VLt-CfWpyMtErZ_NMA130_assertion wasGeneratedBy ECO_0000203 NP109198.RAvIqJjSS6ThU-f_1FhQO7LoXb1VLt-CfWpyMtErZ_NMA130_provenance.